ANIP Oct 2024 70.000 put
| Previous close | 11.80 |
| Open | N/A |
| Bid | 5.30 |
| Ask | 7.50 |
| Strike | 70.00 |
| Expiry date | 2024-10-18 |
| Day's range | 11.80 - 11.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
GlobeNewswireANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows: Date:June 5, 2024 Time:4:30 ET Webcast:Click Here To schedule a 1x1 meeting with the Company, please contact your Jefferies representative. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified bio
ZacksAstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
ZacksDyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
